← Back to Search

Behavioural Intervention

Transdiagnostic Network Informed Personalized Treatment for Eating Disorders (T-NIPT-ED Trial)

N/A

Recruiting

Led By Cheri A Levinson, PhD

Research Sponsored by University of Louisville

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Current diagnosis of any active eating disorder except ARFID

Ages 18-65

Timeline

Screening 3 weeks

Treatment Varies

Follow Up up to 18 weeks

Awards & highlights

T-NIPT-ED Trial Summary

This trial aims to develop a personalized treatment for eating disorders (EDs) by considering individual factors and social context. Current treatments for EDs have limited success, and there is a need for more effective

Who is the study for?

This trial is for adults aged 18-65 with an active eating disorder, excluding ARFID. It's not suitable for individuals who are currently experiencing suicidal thoughts, mania, or psychosis.Check my eligibility

What is being tested?

The study compares a new personalized treatment (T-NIPT-ED) using mobile technology and individual modeling to the standard Cognitive Behavioral Therapy Enhanced (CBT-E) in treating eating disorders.See study design

What are the potential side effects?

Since this trial involves therapy rather than medication, side effects may include emotional discomfort or distress due to discussing personal issues during sessions.

T-NIPT-ED Trial Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

I have an active eating disorder, but it's not ARFID.

Select...

I am between 18 and 65 years old.

T-NIPT-ED Trial Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ up to 18 weeks

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~up to 18 weeks

This trial's timeline: 3 weeks for screening, Varies for treatment, and up to 18 weeks for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Clinical impairment

Eating disorder symptoms

Secondary outcome measures

Health service utilization using the Health Utilization and Medical Comorbidities

Medical comorbidities using the Health Utilization and Medical Comorbidities

Psychological comorbidities using Structured Clinical Interview for DSM-5 (SCID-5)

T-NIPT-ED Trial Design

2Treatment groups

Experimental Treatment

Active Control

Group I: Transdiagnostic Network Informed Personalized TreatmentExperimental Treatment1 Intervention

Participants will receive 1 session of education about the treatment after completing Phase I of the study (two weeks of ecological momentary assessment). Participants will then complete 10 sessions of personalized treatment for eating disorders based on their ecological momentary assessment surveys. Participants will complete one session of relapse prevention at the end.

Group II: Cognitive Behavioral Therapy for Eating DisordersActive Control1 Intervention

Participants will receive 1 session of education about the treatment after completing Phase I of the study (two weeks of ecological momentary assessment). Participants will then complete 10 sessions of Enhanced Cognitive Behavioral Therapy for Eating Disorders (CBT-E. Participants will complete one session of relapse prevention at the end.

0 / 2Eligibility criteria met

Find a Location

Who is running the clinical trial?

University of LouisvilleLead Sponsor

339 Previous Clinical Trials

76,360 Total Patients Enrolled

7 Trials studying Eating Disorders

640 Patients Enrolled for Eating Disorders

National Institute of Mental Health (NIMH)NIH

2,786 Previous Clinical Trials

2,689,379 Total Patients Enrolled

61 Trials studying Eating Disorders

24,840 Patients Enrolled for Eating Disorders

Cheri A Levinson, PhDPrincipal InvestigatorUniversity of Louisville

2 Previous Clinical Trials

210 Total Patients Enrolled

2 Trials studying Eating Disorders

210 Patients Enrolled for Eating Disorders

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Am I eligible to be a part of this medical study?

"In order to be eligible for enrollment in this clinical trial, individuals must have a diagnosis of eating disorders and fall within the age range of 18 to 65 years. The study aims to recruit a total of 320 participants."

Answered by AI

Are there any available positions for participants in this research study?

"Apologies for the confusion. According to the information provided on clinicaltrials.gov, this particular study is no longer recruiting patients as of its last update on January 5th, 2024. However, it's worth noting that there are currently 103 other trials actively seeking participants."

Answered by AI

Is the age criterion for participation in this investigation limited to individuals below 70 years old?

"To be considered eligible for this trial, prospective participants must fall within the age range of 18 to 65. It's worth noting that there are a total of 43 trials specifically designed for individuals under the age of 18 and an additional 50 trials targeting those over the age of 65."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

Innovations in Personalizing Treatment Study

Cheri Levinson 2024. "Innovations in Personalizing Treatment Study". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT06208605.

All > Anorexia Nervosa > Edmonton